Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.
Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L
Breast Cancer Res 2008, 10:R10
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
36%36%

 Viewpoint   
Regulation of cancer stem cells by p53
Jerry DJ, Tao L, Yan H
Breast Cancer Research 2008, 10:304 (29 August 2008)
 [Abstract] [Full text] [PDF]
2.
36%36%

 Review   
Breast cancer stem cells: implications for therapy of breast cancer
Morrison BJ, Schmidt CW, Lakhani SR, Reynolds BA, Lopez JA
Breast Cancer Research 2008, 10:210 (22 July 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
3.
36%36%


 Editorial    
Cancer stem cell heterogeneity in hereditary breast cancer
Wicha MS
Breast Cancer Research 2008, 10:105 (16 April 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
4.
36%36%


 Research    
Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1
Wright MH, Robles AI, Herschkowitz JI, Hollingshead MG, Anver MR, Perou CM, Varticovski L
Molecular Cancer 2008, 7:29 (7 April 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 1 article in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
© 1999-2008 BioMed Central Ltd unless otherwise stated < info@breast-cancer-research.com >   Terms and conditions